Insurance for Life Science by Life Science Specialists

Whether in the United States or abroad, Berkley Life Sciences is solely dedicated to providing premiere insurance coverage for today’s top life sciences companies.

Download PDF

Who We Insure

We provide personalized property and casualty insurance products and services to the following life science markets:

Medical Device Companies

Companies that design, manufacture, and distribute medical instruments and devices for healthcare applications.

Medical Device Software Companies

Organizations that develop software solutions for use in union with medical devices to enhance functionality and patient outcomes.

Medical Drug Companies

Pharmaceutical firms involved in the research, development, manufacturing, and marketing of medications for treating various health conditions.

Biologic Companies

Companies that create biologically derived products, including vaccines, blood components, and gene therapies, for medical use.

Dietary Supplement Companies

Firms that produce and distribute vitamins, minerals, and other supplements intended to enhance health and wellness.

Medical Food Companies

Companies that develop and produce foods formulated explicitly for dietary management of diseases or conditions requiring medical supervision.

Cosmetic Drug Companies

Organizations that create products at the intersection of cosmetics and pharmaceuticals, designed to enhance appearance while providing therapeutic benefits.

Product Development Organizations

Companies offering specialized services in developing, testing, and regulatory approval of life science products.

Profit & Nonprofit R&D

Entities dedicated to conducting research in life sciences, ranging from private companies to academic and non-profit organizations.

Product Testing Laboratories

Laboratories specializing in the testing and validation of life science products, ensuring compliance with regulatory standards and safety requirements.

Medical Product Distributors

Companies that manage the distribution and supply chain logistics for a wide range of medical products, ensuring their availability to healthcare providers.

Drug Discovery Technology

Firms and organizations that develop technologies and methodologies to accelerate the identification and development of new pharmaceutical compounds.

Bioengineering

Companies and research institutions that apply biology and engineering principles to develop innovative solutions in healthcare, agriculture, and environmental management.

Health Informatics

Organizations specializing in the intersection of healthcare and information technology, providing solutions for managing and analyzing health data.

Non-Medical Biotechnology

Companies focused on biotechnology applications beyond healthcare, including agriculture, environmental management, and industrial processes.

Find a Berkley Life Sciences Agent

Ready for an insurance solution that is tailored to your life science business by life science specialists?

Find an Agent

The Latest in Life Science

The Science of Aging

The Science of Aging: Can We Really Slow Down the Clock?

Influencer and tech entrepreneur Bryan Johnson set a bold goal four years ago: to redefine how we approach health and aging. He developed a system that radically alters his diet, sleep, and exercise routines in an effort to reverse his biological age. Johnson is now years into his one-man project, Blueprint, which includes taking over 110 pills per day, undergoing light and sound therapies, and following a strict sleep regimen—all guided by real-time data and a team of specialized doctors.

Cracking the Code: How Epigenetics and Blood Tests Are Changing the Alzheimer’s Landscape

Cracking the Code: How Epigenetics and Blood Tests Are Changing the Alzheimer's Landscape

Alzheimer’s disease, a condition that slowly erodes memory and cognitive function, has long been one of the most formidable challenges in medicine. With a rapidly growing patient population in the U.S., the impact of Alzheimer’s disease is profound and far reaching.

GLP-1 Medications – FDA Guidance and Compounded Products

Not long ago, few outside the medical community had heard of semaglutide and tirzepatide—two drugs in the GLP-1 (glucagon-like peptide-1) receptor agonist class, approved for diabetes management. The medications work by decreasing caloric intake through mimicking the natural hormone GLP-1 normally released in the gut after eating. The GLP-1 agonists bind to receptors in the brain, pancreas and intestines, which helps to regulate insulin release, lower blood sugar levels, slow down digestion, and reduce appetite.